Konstantinos Stavropoulos Selected Research

Konstantinos Stavropoulos Research Topics

Disease

11	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2017
9	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 01/2017
9	Hypertension (High Blood Pressure) 01/2020 - 04/2016
8	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2018
7	Heart Failure 08/2022 - 01/2017
7	Body Weight (Weight, Body) 12/2019 - 01/2017
5	Stroke (Strokes) 01/2019 - 07/2016
4	Hyperaldosteronism (Conn Syndrome) 01/2022 - 01/2018
4	Albuminuria 01/2021 - 01/2017
4	Dyslipidemias (Dyslipidemia) 04/2018 - 01/2017
3	Inflammation (Inflammations) 03/2024 - 01/2018
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2020 - 01/2018
2	COVID-19 01/2022 - 10/2020
2	Diabetes Mellitus 01/2022 - 01/2017
2	Chronic Renal Insufficiency 01/2021 - 01/2018
2	Infections 10/2020 - 01/2018
2	Fibrosis (Cirrhosis) 04/2018 - 01/2018
2	Fatty Liver 04/2018 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 04/2018 - 01/2018
1	Overweight 12/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Critical Illness (Critically Ill) 10/2020
1	Disease Progression 10/2020
1	Autoimmune Diseases (Autoimmune Disease) 07/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Erectile Dysfunction 01/2020
1	Insulin Resistance 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 12/2019
1	Hepatitis 04/2018
1	Liver Diseases (Liver Disease) 04/2018
1	Weight Gain 01/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2018
1	Arteritis 01/2018
1	Hyperglycemia 01/2018
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018
1	Myocardial Infarction 01/2018
1	Obesity 01/2018
1	Alcoholic Fatty Liver 01/2018
1	Thrombosis (Thrombus) 01/2018

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 01/2017
11	SodiumIBA 08/2022 - 01/2017
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2018
6	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019 - 01/2017
5	Mineralocorticoid Receptor AntagonistsIBA 08/2022 - 01/2017
5	Sodium-Glucose Transport ProteinsIBA 10/2019 - 01/2018
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 01/2017
4	SymportersIBA 08/2022 - 01/2017
4	Insulin (Novolin)FDA Link 07/2020 - 01/2018
4	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 01/2017
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2019 - 01/2018
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 01/2018
3	sacubitril and valsartan sodium hydrate drug combinationIBA 08/2022 - 01/2017
3	Pioglitazone (Actos)FDA Link 01/2019 - 01/2018
3	oxidized low density lipoproteinIBA 03/2018 - 01/2018
3	LDL CholesterolIBA 03/2018 - 01/2018
3	Atorvastatin (Lipitor)FDA Link 01/2018 - 01/2018
2	HDL CholesterolIBA 04/2023 - 03/2018
2	EnzymesIBA 01/2018 - 01/2018
2	Vitamin E FDA LinkGeneric 01/2018 - 01/2018
2	AldosteroneIBA 01/2018 - 01/2018
2	Spironolactone (Aldactone)FDA LinkGeneric 01/2018 - 04/2016
2	empagliflozinIBA 11/2017 - 01/2017
2	CanagliflozinIBA 11/2017 - 10/2016
1	CytokinesIBA 03/2024
1	Monoclonal AntibodiesIBA 03/2024
1	MicroRNAs (MicroRNA)IBA 03/2024
1	tirzepatideIBA 12/2023
1	Ranolazine FDA Link 01/2022
1	Carrier Proteins (Binding Protein)IBA 10/2021
1	C-Reactive ProteinIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 10/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	IronIBA 01/2020
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2020
1	PTX3 proteinIBA 01/2019
1	ThiazolidinedionesIBA 01/2019
1	LeptinIBA 01/2019
1	Ezetimibe (Zetia)FDA Link 01/2019
1	MineralocorticoidsIBA 12/2018
1	Triglycerides (Triacylglycerol)IBA 03/2018
1	Fibric Acids (Fibrates)IBA 03/2018
1	PotassiumIBA 01/2018
1	Trinitrotoluene (TNT)IBA 01/2018
1	Uric Acid (Urate)IBA 01/2018
1	Drug CombinationsIBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2020 - 11/2017
2	Adrenalectomy 01/2022 - 01/2018
2	Denervation 01/2020 - 11/2019
2	Glycemic Control 12/2019 - 01/2018
1	Secondary Prevention 01/2021
1	Catheters 01/2020